JAKOB LOVEN

Profile

First Name

: JAKOB

Middle Name

:

Last Name

: LOVEN

Related Companies
Titles
Company Name
Related People
DIRECTOR
ARVINAS HOLDING COMPANY, LLC
SEAN CASSIDY, JOHN D. HOUSTON, JOHN G. HOUSTON, EDWARD KENNEDY, JR., ANDREW LEVIN, MANUEL LITCHMAN, BRAD MARGUS, BRADLEY MARGUS, BRIGGS MORRISON, KUSH PARMAR, LIAM RATCLIFFE, TIM SHANNON, TIMOTHY SHANNON, JONATHAN SODERSTROM, STEPHEN SQUINTO, IAN TAYLOR
DIRECTOR
VIVIDION THERAPEUTICS, INC.
PATRICIA L. ALLEN, FRED ASLAN, KRISTINA BUROW, JOHN CLARKE, JOHN K. CLARKE, BENJAMIN CRAVATT, THOMAS E. DANIEL, TOM DANIEL, JEFFREY HATFIELD, RICHARD HEYMAN, DIEGO K. MIRALLES, JOHN PARK, THOMAS WOIWODE
DIRECTOR
ARRAKIS THERAPEUTICS, INC.
COLLEEN CUFFARO, RICHARD GASTER, MICHAEL GILMAN, CAROLYN GREEN, DAVID NEAFUS, RAJ PAREKH, RUSSELL C. PETTER, NIKOLA TRBOVIC, ALAN E. WALTS
DIRECTOR
ARVINAS, INC.
SEAN CASSIDY, JOHN D. HOUSTON, JOHN G. HOUSTON, EDWARD KENNEDY, JR., ANDREW LEVIN, MANUEL LITCHMAN, BRAD MARGUS, BRADLEY MARGUS, BRIGGS MORRISON, KUSH PARMAR, LIAM RATCLIFFE, TIM SHANNON, TIMOTHY SHANNON, JONATHAN SODERSTROM, STEPHEN SQUINTO, IAN TAYLOR
DIRECTOR
A2 BIOTHERAPEUTICS, INC.
SRINI AKKARAJU, MADHAVAN BALACHANDRAN, SCOTT FORAKER, MICHAEL GALLO, WILLIAM GO, DAVID GOEDDEL, ALEXANDER KAMB, C. ALEXANDER KAMB, SUSAN L. KELLEY, HELEN S. KIM, THOMAS LEUNG, DAVID LUCAS
DIRECTOR
ICONOVIR BIO, INC.
SEAN ALGEO, ARIE S. BELLDEGRUN, DAVID CHANG, JOHN HUYNH, WILLIAM KAELIN, JOSHUA KAZAM, JOSHUA A. KAZAM, HELEN S. KIM, JULIE MALTZMAN, MARK A. MCCAMISH, HEBA NOWYHED, DAVID M. TANEN, NICOLE VAN DE LEUV
DIRECTOR
HEXAGON BIO INC.
DAVID GOEDDEL, COLIN JAMES BELL HARVEY, MAUREEN HILLENMEYER, MAUREEN E HILLENMEYER, MAUREEN E. HILLENMEYER, JUAN JAEN, ALEX KOLICH, ALEX KOLICICH, BRIAN NAUGHTON, BRIAN T NAUGHTON, BRIAN T. NAUGHTON, MRIDULA RAY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-06-06 
2023-06-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-06-06 
2022-12-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2022-11-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2022-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
2021-07-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-11 
2021-03-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-18 
2020-12-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-01 
2020-10-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-30 
2020-10-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-30 
2019-07-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-07-16 
2019-05-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-24 
2019-04-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-15 
2018-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-29